Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients

American Journal of Clinical Nutrition

Volumn 79, Issue 6, 2004, Pages 1045-1052

  Schupp, Christine ^a   Olano Martin, Estibaliz ^a   Gerth, Christina ^a   Morrissey, Brian M ^a   Cross, Carroll E ^a   Werner, John S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Section of Neurobiology   (United States)

Author keywords

Carotenoids; Color vision; Contrast sensitivity; Cystic fibrosis; Electroretinogram; Lutein; Macular pigment; Zeaxanthin

Indexed keywords

XANTHOPHYLL; ZEAXANTHIN; BETA CAROTENE; DRUG DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR DISCRIMINATION; COLOR VISION; COMPARATIVE STUDY; CONTRAST SENSITIVITY; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTRORETINOGRAPHY; HUMAN; LIGHT ABSORPTION; OPTICAL DENSITY; PIGMENT EPITHELIUM; RETINA CONE; RETINA MACULA LUTEA; SAMPLE SIZE; VISUAL DISCRIMINATION; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA;

ADULT; BETA CAROTENE; CASE-CONTROL STUDIES; COLOR PERCEPTION; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; LUTEIN; MALE; MIDDLE AGED; RETINA; XANTHOPHYLLS;

EID: 3042766292     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.6.1045     Document Type: Article

References (50)

1. Welsh MJ, Tsui IT, Boat TF, Beaudet AL. The metabolic basis of inherited disease. New York: McGraw Hill, 1995.
2. Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr 1992;55:108-16.
3. Homnick DN, Spillers CR, Cox SR, et al. Single- and multiple-dose- response relationships of beta-carotene in cystic fibrosis. J Pediatr 1995; 127:491-4.
4. Winklhofer-Roob BM, Puhl H, Khoschsorur G, van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during betacarotene supplementation in cystic fibrosis. Free Radic Biol Med 1995; 18:849-59.
5. Winklhofer-Roob BM, Schlegel-Haueter SE, Khoschsorur G, van't Hof MA, Suter S, Shmerling DH. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation. Pediatr Res 1996; 40:130-4.
6. Lepage G, Champagne J, Ronco N, et al. Supplementation with carote-noids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996;64:87-93.
7. Rust P, Eichler I, Renner S, Elmadfa I. Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Ann Nutr Metab 2000;44:30-7.
8. Renner S, Rath R, Rust P, et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 2001;56:48-52.
9. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994;36:487-93.
10. van der Vliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE. Oxidative stress in cystic fibrosis: does it occur and does it matter? Adv Pharmacol 1997;38:491-513.
11. Cobanoglu N, Ozcelik U, Gocmen A, Kiper N, Dogru D. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatr 2002;91:793-8.
12. Hull J, Vervaart P, Grimwood K, Phelan P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997;52:557-60.
13. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am J Clin Nutr 2002;75:668-75.
14. Burton GW. Antioxidant action of carotenoids. J Nutr 1989;119:109-11.
15. Krinsky NI, Yeum KJ. Carotenoid-radical interactions. Biochem Biophys Res Commun 2003;305:754-60.
16. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 1992;32:105-10.
17. Schalch W, Dayhaw-Barker P, Barker FM. ed, Nutritional and environmental influences on the eye. Boca Raton, FL: CRC Press, 1999.
18. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62(suppl):1448S-61S.
19. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 2002;120:1357-63.
20. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol 2001; 153:424-32.
21. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23:171-201.
22. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A 2000;17:1918-32.
23. Hammond BR Jr, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci 1998;39:397-406.
24. Spaide RF, Diamond G, D'Amico RA, Gaerlan PF, Bisberg DS. Ocular findings in cystic fibrosis. Am J Ophthalmol 1987;103:204-10.
25. Ansari EA, Sahni K, Etherington C, et al. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. Br J Ophthalmol 1999;83:688-91.
26. Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest 2003;111:565-70.
27. Obermueller-Jevic UC, Espiritu I, Corbacho AM, Cross CE, Witschi H. Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol Sei 2002;69:23-9.
28. Werner JS, Wooten BR. Opponent chromatic mechanisms: relation to photopigments and hue naming. J Opt Soc Am 1979;69:422-34.
29. Wooten BR, Hammond BR Jr, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40:2481-9.
30. Schefrin BE, Tregear SJ, Harvey LO Jr, Werner JS. Senescent changes in scotopic contrast sensitivity. Vision Res 1999;39:3728-36.
31. Harvey LO. Efficient estimation of sensory thresholds. Behav Res Methods Instr Computers 1986;18:623-32.
32. Krastel H, Moreland D. Colour vision deficiencies in ophthalmic diseases. In: Foster DH, ed. Inherited and acquired colour vision deficiencies. Boston: CRC Press, Inc, 1991:115-72.
33. Sperling HG. Vulnerability of the blue-sensitive mechanism. In: Foster DH, ed. Inherited and acquired colour vision deficiencies. Boston: CRC Press, Inc, 1991:72-87.
34. Reffin JP, Astell S. Trials of a computer-controlled colour vision test that preserves the advantages of pseudoisochromatic plates. In: Drum B, Moreland D, Serra A, eds. Colour vision deficiencies. London: Kluwer Academic Publishers, 1991:69-76.
35. Sutter EE. The fast m-transform: a fast computation of cross-correlations with binary m-sequences. SIAM J Comput 1991;20:686-94.
36. Gerth C, Garcia SM, Ma L, Keltner JL, Werner JS. Multifocal electroretinogram: age-related changes for different luminance levels. Graefes Arch Clin Exp Ophthalmol 2002;240:202-8.
37. Rock CL, Thomquist MD, Neuhouser ML, et al. Diet and lifestyle correlates of lutein in the blood and diet. J Nutr 2002;132:525S-30S.
38. Movshon JA, Kiorpes L. Analysis of the development of spatial contrast sensitivity in monkey and human infants. J Opt Soc Am A 1988;5:2166-72.
39. Regan BC, Reffin JP, Mollon JD. Luminance noise and the rapid determination of discrimination ellipses in colour deficiency. Vis Res 1993; 34:1279-99.
40. Curran-Celentano J, Hammond BR Jr, CiullaTA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001;74:796-802.
41. Cross CE, Traber M, Eiserich J, van der Vliet A. Micronutrient antioxidants and smoking. Br Med Bull 1999;55:691-704.
42. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 1987;27:257-68.
43. Stahl W, Junghans A, de Boer B, Driomina ES, Briviba K, Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 1998;427: 305-8.
44. Suttle CM, Harding GF. The VEP and ERG in a young infant with cystic fibrosis. A case report. Doc Ophthalmol 1998;95:63-71.
45. Leguire LE, Pappa KS, McGregor ML, Rogers GL, Bremer DL. Electrooculogram in vitamin A deficiency associated with cystic fibrosis. Short communication. Ophthalmic Paediatr Genet 1992;13:187-9.
46. Keith CG, De Haller J, Young WF. Side-effects to antibiotics in cystic fibrosis. I: ocular changes in relation to antibiotic administration and to severity of pulmonary involvement. Arch Dis Child 1966;41:262-6.
47. Klein R, Klein BEK, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam eye study. Am J Epidemiol 2002;156:589-98.
48. Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol 2003;121:1404-14.
49. Schunemann HJ, McCann S, Grant BJ, Trevisan M, Muti P, Freudenheim JL. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002; 155:463-71.
50. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.